Patents by Inventor Frank J. Rauscher, III

Frank J. Rauscher, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation for reducing frequency of urination and method of use thereof
    Patent number: 10010514
    Abstract: Methods and compositions for reducing frequency of urination are disclosed. The methods comprise administering to a subject having a condition that resulting in undesired frequency of urination an effective amount of a pharmaceutical composition comprising one or more prostaglandin pathway inhibitors. The pharmaceutical compositions comprise one or more prostaglandin pathway inhibitors and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: July 3, 2018
    Assignee: WELLESLEY PHARMACEUTICALS, LLC
    Inventors: David A. Dill, Frank J. Rauscher, III
  • PHARMACEUTICAL FORMULATION FOR REDUCING FREQUENCY OF URINATION AND METHOD OF USE THEREOF
    Publication number: 20170049729
    Abstract: Methods and compositions for reducing frequency of urination are disclosed. The methods comprise administering to a subject having a condition that resulting in undesired frequency of urination an effective amount of a pharmaceutical composition comprising one or more prostaglandin pathway inhibitors. The pharmaceutical compositions comprise one or more prostaglandin pathway inhibitors and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: October 11, 2016
    Publication date: February 23, 2017
    Inventors: David A. DILL, Frank J. RAUSCHER, III
  • Pharmaceutical formulation for reducing frequency of urination and method of use thereof
    Patent number: 9532959
    Abstract: Methods and compositions for reducing frequency of urination are disclosed. The methods comprise administering to a subject having a condition that resulting in undesired frequency of urination an effective amount of a pharmaceutical composition comprising one or more prostaglandin pathway inhibitors. The pharmaceutical compositions comprise one or more prostaglandin pathway inhibitors and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: June 6, 2014
    Date of Patent: January 3, 2017
    Assignee: WELLESLEY PHARMACEUTICALS, LLC
    Inventors: David A. Dill, Frank J. Rauscher, III
  • PHARMACEUTICAL FORMULATION FOR REDUCING FREQUENCY OF URINATION AND METHOD OF USE THEREOF
    Publication number: 20140287003
    Abstract: Methods and compositions for reducing frequency of urination are disclosed. The methods comprise administering to a subject having a condition that resulting in undesired frequency of urination an effective amount of a pharmaceutical composition comprising one or more prostaglandin pathway inhibitors. The pharmaceutical compositions comprise one or more prostaglandin pathway inhibitors and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: June 6, 2014
    Publication date: September 25, 2014
    Inventors: David A. Dill, Frank J. Rauscher, III
  • BRCA1 associated polynucleotide (BAP-1) and uses therefor
    Patent number: 6307035
    Abstract: Nucleic acid and amino acid sequences of a BRCA1 associated protein, BAP-1, are provided. These sequences, the protein, and anti-BAP-1 antibodies are useful in therapeutics and diagnostics for cancers associated with loss of the 3p21 chromosomal region and/or inappropriate BAP-1 levels.
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: October 23, 2001
    Assignee: The Wistar Institute of Anatomy and Biology
    Inventors: Frank J. Rauscher, III, David E. Jensen
  • WT1 monoclonal antibodies and methods of use therefor
    Patent number: 5633142
    Abstract: The present invention provides three unique monoclonal antibodies directed against a portion of the Wilms' tumor antigen, and methods of use therefor in detecting, monitoring and diagnosing malignancies characterized by over-expression or inappropriate expression of the WT 1 protein.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: May 27, 1997
    Assignee: The Wistar Institute of Anatomy and Biology
    Inventors: Meenhard Herlyn, Jennifer Morris, Frank J. Rauscher, III, Ulrich Rodeck
  • WT1 monoclonal antibodies
    Patent number: 5622835
    Abstract: Three unique monoclonal antibodies, each having an epitope located in amino acids 1-181 of the WT1 tumor protein, and the hybridomas which secrete them have been constructed. These monoclonal antibodies are useful in the detection, monitoring, and diagnosis of malignancies characterized by inappropriate expression of the WT1 protein.
    Type: Grant
    Filed: April 28, 1994
    Date of Patent: April 22, 1997
    Assignee: The Wistar Institute of Anatomy & Biology
    Inventors: Meenhard Herlyn, Jennifer Morris, Frank J. Rauscher, III, Ulrich Rodeck